Spots Global Cancer Trial Database for Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Official Title: Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Study ID: NCT00001158
Interventions
Study Description
Brief Summary: The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Detailed Description: The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
National Cancer Institute (NCI), Bethesda, Maryland, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
